Investing
The life science company plans to launch its open research tool in 2022.
The company is set to debut in the KOSDAQ early next year.
Lindera’s ‘SturzApp’ facilitates motion analysis via an app, using smartphone or tablet cameras to track movement and reduce the risk of falls in seniors.
Polish-based Docplanner steps up expansion plans in Germany.
The firm plans to further develop its blood typing technology.
The Series C brings its total raise to $160 million.
Funding will help take its DTx solutions through regulatory approvals and to market in the UK and US.
Global healthtech has received $51.3 billion in investment this year, marking new highs for venture capitalist interest in the sector and identifying London as the fastest growing healthtech hub globally.
Also: RenalSense scores $14 million for its renal diagnostic, and InsurMedix rakes in $15 million for fertility insurance.
SWORD raised $163 million in Series D funding, which allowed for a secondary round where it scooped up another $26 million.